Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 22 (5%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 381 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-10-08 | 2024-02-15 | 146947 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2020-02-27 | 2020-04-08 | 107312 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2021-08-03 | 2022-04-05 | 143447 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2021-10-08 | 2022-04-06 | 146927 |
| TERBINAFINE | 250MG | TABLET | Resolved | 2019-08-06 | 2019-10-02 | 90836 |
| MELOXICAM | 7.5MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85269 |
| MELOXICAM | 15MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85272 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2019-01-15 | 2019-02-20 | 72239 |
| LOVASTATIN | 20MG | TABLET | Resolved | 2019-06-27 | 2019-07-26 | 87568 |
| LOVASTATIN | 20MG | TABLET | Resolved | 2020-01-21 | 2024-03-02 | 103762 |
| LOVASTATIN | 40MG | TABLET | Resolved | 2020-01-21 | 2024-03-02 | 103759 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-12-15 | 2017-12-22 | 33110 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-22 | 2017-12-22 | 30110 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-04-28 | 2021-12-07 | 138161 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-09-30 | 2021-12-07 | 146477 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |